growth factor (EGF) receptor and v-src-associated tyrosine kinase1 )2) and EGF-induced DNAsynthesis in quiescent NRK cells3), and induces normal phenotypes in Rous sarcoma virus-transformed NRK (RSV-NRK) cells4). Erbstatin also inhibits growth of humanbreast carcinoma MCF-7trans-planted in nude mice5). However, it is unstable and easily degraded in serum6) and in cell culture medium (K. Umezawa; unpublished results). Therefore, we synthesized methyl 2,5-dihydroxycinnamate (2,5-MeC) as a stable analogue of erbstatin3).
It inhibited EGF-induced S-phase entry3), cellular src functions4), and in vivo growth of MCF-7tumors (Dr. M. Toi, Hiroshima University; personal communication) more prominently than erbstatin. In this presently reported study we synthesized several new alkyl dihydroxycinnamates and an aldehyde derivative as more stable analogues of erbstatin and examined their inhibitory activity on tyrosine kinase and cellular src oncogene functions.
We synthesized alkyl 2,5-dihydroxycinnamates7) and 2,3-dihydroxycinnamates8). The structures of these new erbstatin derivatives are shownin Fig. 1 . The inhibition of EGF receptor-associated tyrosine kinase by them and their cytotoxicity toward A431 cells are summarized in Table 1 . The tyrosine kinase activity was assayed as described before3) with the peptide RR-SRC as substrate and the A431 cell membraneas an enzyme source. Cell growth was assayed by counting the cell number after 3 days of incubation of the cells in Dulbecco's modified
Eagle's medium supplemented with 5% calf serum.
The ethyl and propyl 2,5-esters showed similar enzyme inhibitory activity to those of erbstatin and 2,5-MeC. Further elongation of the aliphatic structure slightly decreased the inhibitory activity. The 2,3-dihydroxy derivative oferbstatin was shown to be more potent than erbstatin in inhibition of tyrosine kinase9); but it showed no biological effect in cell culture, possibly because of poor permeability through the plasma membrane.So we prepared butyl and hexyl esters of 2,3-dihydroxycinnamic acid. The hexyl derivative showed weaker inhibitory potency than 2,3-BuC. As shown in Table 1 , large aliphatic or aromatic ester showed weaker cytotoxicity toward A431 cells. The stability of 2,5-and 2,3-dihydroxycinnamates and 2,5-Cal in calf serum is shown in Fig. 2 . The stability was assayed as described before3). The butyl, hexyl, or benzyl esters were more stable than the esters with a shorter aliphatic chain. Also, the 2,3-derivatives were more stable than the 2,5-derivatives.
Induction of normal morphology in RSVts-NRK cells was determined by phase-contrast microscopy as described earlier40. Normal morphology was most effectively induced by 2,5-MeC and 2,5-EtC among the 2,5-dihydroxycinnamates, as shown in Table 2 . Elongation of the aliphatic chain reduced the activity. For the 2,3-derivatives, 2,3-HeC was more effective than 2,3-BuC in induction of normal phenotypes.
Although erbstatin and 2,5-MeC show antitumour activity against transplanted humantumours, their effective dosage (1~4 mg/mouse) is so high that further development will be difficult. It is highly desirable to find more effective and stable tyrosine kinase inhibitors. The new erbstatin analogues described here were not more effective in inhibition of the enzyme, but their stability in serum was greatly enhanced.
Chemistry, and Drs. S. Umezawa, T. Tsuchiya, and T. 
